Canine parvovirus type 2c identified from an outbreak of severe gastroenteritis in a litter in Sweden |
| |
Authors: | David Sutton Carina Vinberg Agneta Gustafsson Jacqueline Pearce Neil Greenwood |
| |
Affiliation: | 1.MSD Animal Health, Walton Manor, Walton, Milton Keynes, MK7 7AJ, UK;2.Helsingborg Animal Hospital, Box 220 97, Helsingborg, SE-250 23, Sweden;3.MSD Animal Health, Box 7121, Sollentuna, SE-192 07, Sweden |
| |
Abstract: | A litter of recently-vaccinated puppies in Sweden experienced signs of severe haemorrhagic gastroenteritis. Canine parvovirus (CPV) was suspected as the cause of this outbreak on the basis of the clinical signs and the presence of parvoviral antigen in the faeces from one of the affected pups - confirmed using a commercial in-clinic faecal antigen ELISA test kit. A concern was raised about whether the vaccine (which contained a live, attenuated strain of CPV) could have caused the disease and so further faecal samples from the affected pups were submitted for laboratory virus isolation and identification.On cell culture, two out of four faecal samples were found to be virus-positive. This was confirmed as being canine parvovirus by immuno-staining with CPV specific monoclonal antibody. The virus was then tested using a series of PCR probes designed to confirm the identity of CPV and to distinguish the unique vaccine strain from field virus. This confirmed that the virus was indeed CPV but that it was not vaccine strain. The virus was then typed by sequencing the 426 amino acid region of the capsid gene which revealed this to be a type 2c virus.Since its emergence in the late 1970s, canine parvovirus 2 (CPV2) has spread worldwide and is recognised as an important canine pathogen in all countries. The original CPV2 rapidly evolved into two antigenic variants, CPV2a and CPV2b, which progressively replaced the original CPV2. More recently a new antigenic variant, CPV2c, has appeared. To date this variant has been identified in many countries worldwide but there have been no reports yet of its presence in any Scandinavian countries. This case report therefore represents the first published evidence of the involvement of CPV2c in a severe outbreak of typical haemorrhagic gastroenteritis in a susceptible litter of pups in Scandinavia. |
| |
Keywords: | Dog Haemorrhagic gastroenteritis Vaccination CPV2c Sweden |
|
|